Oramed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $2,000 | $0 | $0 | $0 |
Gross Profit | 13 | |||
EBITDA | -3,037 | 11,153 | ||
EBIT | -3,089 | 11,099 | ||
Net Income | -7,642 | -10,189 | -19,619 | 9,212 |
Net Change In Cash | 2,000 | 0 | 0 | 0 |
Free Cash Flow | -3,522 | -1,922 | -7,106 | 2,076 |
Cash | 74,516 | 54,420 | 42,104 | 84,753 |
Basic Shares | 40,850 | 39,919 | 40,896 | 41,591 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,340 | $2,703 | $2,703 |
Gross Profit | 1,340 | 2,703 | 2,703 | |
EBITDA | -15,573 | -36,976 | -25,039 | |
EBIT | -15,769 | -40,598 | -25,116 | |
Net Income | -19,060 | 5,525 | -37,764 | -22,238 |
Net Change In Cash | 0 | 1,340 | 2,703 | 2,703 |
Free Cash Flow | -8,430 | -10,549 | -28,414 | -21,556 |
Cash | 54,420 | 9,055 | 40,464 | 77,245 |
Basic Shares | 39,919 | 40,566 | 38,997 | 28,469 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.31 |
2025-03-31 | -$0.19 |
2024-12-31 | -$0.25 |
